C P Quinn - JoVE Visualize

Showing results (11-20 of 29) with videos related to

Pageof 3

Sort By:

Medical Microbiology and Immunology|January 1, 1988

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunityP C Turnbull, S H Leppla, M G Broster, et al.

European Journal of Biochemistry|November 1, 1993

Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxinC C Shone, C P Quinn, R Wait, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998

Continuous amperometric monitoring of glucose in a brittle diabetic chimpanzee with a miniature subcutaneous electrodeJ G Wagner, D W Schmidtke, C P Quinn, et al.

Growth Factors (Chur, Switzerland)|October 6, 2000

A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitter release in vitroJ A Chaddock, J R Purkiss, M J Duggan, et al.

Protein Science : a Publication of the Protein Society|August 1, 1996

Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolutionA C Papageorgiou, C P Quinn, D Beer, et al.

The American Journal of Physiology|July 1, 1995

Kinetics of glucose delivery to subcutaneous tissue in rats measured with 0.3-mm amperometric microsensorsC P Quinn, M V Pishko, D W Schmidtke, et al.

Vaccine|August 26, 2016

Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparingG V Stark, G S Sivko, M VanRaden, et al.

Vaccine|January 19, 2007

Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthraxV A Semenova, D S Schmidt, T H Taylor, et al.

Analytical Chemistry|October 1, 1994

Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrodeE Csöregi, C P Quinn, D W Schmidtke, et al.

Clinical and Diagnostic Laboratory Immunology|September 11, 2004

Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serumV A Semenova, E Steward-Clark, K L Stamey, et al.

Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:

Pageof 3

Medical Microbiology and Immunology|January 1, 1988

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunityP C Turnbull, S H Leppla, M G Broster, et al.

European Journal of Biochemistry|November 1, 1993

Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxinC C Shone, C P Quinn, R Wait, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998

Continuous amperometric monitoring of glucose in a brittle diabetic chimpanzee with a miniature subcutaneous electrodeJ G Wagner, D W Schmidtke, C P Quinn, et al.

Growth Factors (Chur, Switzerland)|October 6, 2000

A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitter release in vitroJ A Chaddock, J R Purkiss, M J Duggan, et al.

Protein Science : a Publication of the Protein Society|August 1, 1996

Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolutionA C Papageorgiou, C P Quinn, D Beer, et al.

The American Journal of Physiology|July 1, 1995

Kinetics of glucose delivery to subcutaneous tissue in rats measured with 0.3-mm amperometric microsensorsC P Quinn, M V Pishko, D W Schmidtke, et al.

Vaccine|August 26, 2016

Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparingG V Stark, G S Sivko, M VanRaden, et al.

Vaccine|January 19, 2007

Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthraxV A Semenova, D S Schmidt, T H Taylor, et al.

Analytical Chemistry|October 1, 1994

Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrodeE Csöregi, C P Quinn, D W Schmidtke, et al.

Clinical and Diagnostic Laboratory Immunology|September 11, 2004

Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serumV A Semenova, E Steward-Clark, K L Stamey, et al.

Pageof 3